Army EEBC, USAMRIID Continue Fight Against Ebola

By Tactical-Life

The following is a release from the U.S. Army Edgewood Chemical Biological Center:

The U.S. Army Edgewood Chemical Biological Center, or ECBC, and the U.S. Army Medical Research Institute of Infectious Diseases, or USAMRIID, are partnering to help expedite progress in the global fight against Ebola.

ECBC is working with USAMRIID on two critical studies – a vaccine study and a biomarker study – that will advance the global fight against Ebola.

• RELATED STORY: Army Focusing on Comm Network During Ebola Outbreak in West Africa

Ebola is a rare and deadly disease caused by infection with the Ebola virus. The largest Ebola outbreak in history, which began in December 2013, is still ongoing. This disease has a high death rate – to date, there have been 22,000 cases and 9,000 deaths attributed to the most recent outbreak – with no known cure or effective vaccine. ECBC and USAMRIID are trying to change that.

USAMRIID, the Department of Defense’s lead laboratory for medical biological defense research, called upon the ECBC-US Army Medical Research Institute of Chemical Defense Mass Spectrometry Core Facility to assist with two of its ongoing Ebola research programs – characterizing a potential vaccine and identifying biomarkers of infection.

For the vaccine …read more

Source:: Tactical Life